reference/12866061

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12866061

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	7383
issn	0950-9232 1476-5594
issueIdentifier	49
pageRange	7367-7383
publicationName	Oncogene
startingPage	7367
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7c5543927fa920879f84d4912569a7e3 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cc88d3ea1a6f9693f11dd380c2722371 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0f0a9b967ef5afea2bc61b2075ee596a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7c87fe0987dd9fec7e5265e647a01305 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_848e17e608c93f2c94ab6227f249589c
bibliographicCitation	Liu HJ, Lam HC, Baglini CV, Nijmeh J, Cottrill AA, Chan SY, Henske EP. Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ). Oncogene. 2019 Dec;38(49):7367–83. PMID: 31420607; PMCID: PMC6895402.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_990c3da181e16e104d2e011124074bed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30c4b5d9735e815052f908ed6c5c3644 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9d5cd8bd7f683e92536a9be31d71329 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7811c7074d660343f76b7b6645676488 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f86dbfd7ad309a6bfbf8c0be5111f89a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1de438b80ff7fcd8f1a525928c4a0cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c09ac0159c7d356fd28b4c7defeff6a
date	2019-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/s41388-019-0957-5 https://pubmed.ncbi.nlm.nih.gov/PMC6895402 https://pubmed.ncbi.nlm.nih.gov/31420607
isPartOf	https://portal.issn.org/resource/ISSN/1476-5594 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6325 https://portal.issn.org/resource/ISSN/0950-9232
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ)
discusses	http://id.nlm.nih.gov/mesh/M0029863 http://id.nlm.nih.gov/mesh/M0407989 http://id.nlm.nih.gov/mesh/M0001348 http://id.nlm.nih.gov/mesh/M0502173 http://id.nlm.nih.gov/mesh/M0239300 http://id.nlm.nih.gov/mesh/M0543476 http://id.nlm.nih.gov/mesh/M0220793 http://id.nlm.nih.gov/mesh/M0579317 http://id.nlm.nih.gov/mesh/M0027390
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7173 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_75b1cb2b3111061c7bf9fd1929c12890 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_823fcecddb856aff97395f6263c49881 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282375 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_646caaa7c99b02cebac462a51ebcdd71 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10113 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3c33894421ec07809347e7b0b7b19359 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8077

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID28019 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID218772

Total number of triples: 58.